Alvotech and LOTTE Biologics Sign US Manufacturing Deal

Alvotech and LOTTE Biologics have entered into a US-based manufacturing agreement to increase global supply of biosimilar products. The collaboration will leverage LOTTE Biologics' Syracuse, New York facility and aims to expand Alvotech's manufacturing capacity to meet growing demand.